Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesB cell depletion in lupus and Sjogrens syndrome: An update
Current Opinion in Rheumatology, 08/18/09
Coca A et al. – Study reports that despite the disappointing results of 2 phase III trials, other evidence continues to be published in support of the notion that B cell depletion could be useful for patients with refractory disease, including lupus nephritis, and antibody-mediated cytopenias, possibly in combination with other immunosuppressant medication.
Methods- Review summarizes recent advances in the field of B cell depletion in SLE and Sjögren's syndrome
- Reports of successful B cell depletion therapy in refractory SLE are on the rise
- In contrast, 2 phase III trials employing B cell depletion with rituximab in nonlupus and lupus nephritis (Explorer and Lunar, respectively) did not achieve any success
- Multiple reasons, including:
- Trial design
- Limitations of outcome instruments and sort follow-up
- have been invoked to explain these disconcerting results
- In the representative studies addressing B cell depletion complete and partial remission in lupus nephritis has been achieved in 60-89% of cases
- Improvements in BILAG and SLEDAI scores were associated with decrease in anti-dsDNA and increase in complement levels
- B cell depletion seemed quite efficacious also in pediatric SLE
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögrens syndrome
Arthritis & Rheumatism, 11/06/09A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Rheumatology, 10/23/09Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09Today in Systemic Lupus (SLE)...keeping you current
Receive free subspecialty "5-minute updates" via email
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial
Annals of Rheumatic Diseases, 11/10/09Influence of race/ethnicity on response to lupus nephritis treatment: The ALMS study
Rheumatology, 11/24/09
Sponsor
Article Search
Sponsor